Skip to main content

Streamline Your Mycoplasma Testing With BIOFIRE® Mycoplasma

In the high-stakes world of cell and gene therapy, timely and accurate mycoplasma testing is crucial. BIOFIRE® Mycoplasma delivers a transformative solution with its 1-hour in-house testing, designed to maximize efficiency and cut costs without compromising quality.

BIOFIRE Mycoplasma

BIOFIRE® Mycoplasma Offers Cell & Gene Therapy Manufacturers the “Molecular Lab in a Pouch”:

BIOFIRE® Mycoplasma uses next-gen PCR technology to deliver in-house testing results in under an hour, saving you time and money on outsourced testing without adding significant workload. 

With just two minutes of hands-on time, its simple three-step workflow requires no expertise and no result interpretation. The closed “molecular lab in a pouch” enables data integrity, making rapid, reliable mycoplasma results possible.

   

Why BIOFIRE® Mycoplasma for Cell & Gene Therapies?

  • Fast Results
    Get reliable mycoplasma results in under one hour with BIOFIRE® Mycoplasma’s next-gen PCR technology, reducing dependence on costly outsourced testing.
  • Simple Workflow
    Perform accurate testing easily with a three-step process that requires only two minutes of hands-on time and no result interpretation.
  • Secure and Efficient
    Enjoy a “molecular lab in a pouch” with a closed-system design that enables data integrity and integrates seamlessly into your lab.
  • Cost Savings
    Cut costs and improve efficiency by bringing mycoplasma testing in-house, eliminating expenses for outsourced services and optimizing lab resources.

BIOFIRE Mycoplasma

Interested in Saving Time and Money While Improving Your Testing Accuracy?

Contact our experts today for more information on BIOFIRE® Mycoplasma.

Please accept targeting cookies to allow content

Discover how BIOFIRE® Mycoplasma “Molecular Lab in a Pouch” Automates Testing with a Shorter Time-To-Result

BIOFIRE Mycoplasma Webinar

On-Demand Webinar

Regulatory Submission Strategy for Implementation and Validation of a New PCR-Based Technology for Mycoplasma Testing

Experts from Janssen, Pharmaceutical Companies of Johnson & Johnson, discuss their validation approach and strategy for PCR-based mycoplasma testing.

ACCESS WEBINAR
BIOFIRE Mycoplasma

PRODUCT PAGE

BIOFIRE® MYCOPLASMA

Did you know mycoplasma testing could be so easy? Discover the value of simplicity and take control of your process.

MORE DETAILS
BIOFIRE Mycoplasma Scientific Summary

Scientific Study Summary

BIOFIRE® Mycoplasma For Cell & Gene Therapy Samples

Two cell therapy and four bioproduction manufacturers evaluted the BIOFIRE® FILMARRAY® 2.0 — interested in the results in an easy-to-digest format? Download a one page Scientific Study Summary that details the study's objectives, outline, and conclusion!

DOWNLOAD
Cells

Cell & Gene Therapy Solutions

There’s no time to lose when a patient relies on your product. Streamlined quality control testing specific to cell and gene therapies yields safe, rapid and efficient results.

Discover Our Proven Portfolio Of Value-Added Solutions